Spire Wealth Management Corbus Pharmaceuticals Holdings, Inc. Transaction History

Spire Wealth Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	BUY	$0.21 - $0.53 $423 - $1,069	2,018 New	2,018 $1,000
Q1 2022 Apr 18, 2022	SELL	$0.32 - $0.67 $14,400 - $30,150	-45,000 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$0.6 - $1.11 $27,000 - $49,950	45,000 New	45,000 $28,000
Q2 2021 Jul 26, 2021	SELL	$1.39 - $2.21 $83,400 - $132,600	-60,000 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$1.27 - $3.42 $76,200 - $205,200	60,000 New	60,000 $117,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.